Clinical trials: Vasodilatory Shock, active
Vasodilatory Shock
Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension
The goal of this clinical trial is to determine the safety and efficacy of Angiotensin-II in the treatment of pediatric patients in fluid refractory vasodilatory shock.
- Trial name
- NCT07212686
- Testing
- Angiotensin-II
- Where
- 2 sites in United States
- Volunteers
- 30 people
- Sponsor
- Northwell Health
Septic Shock, Cirrhosis
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure.
- Conditions
- Septic Shock, Cirrhosis, Vasodilatory Shock, Acute Kidney Injury
- Trial name
- Ang2 (NCT07568275)
- Testing
- Giapreza
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- The Cleveland Clinic
Vasodilatory Shock
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
A randomized, double-blind, placebo-controlled study on the treatment of refractory distributed shock with angiotensin II injection, with a random ratio of 1:1.
- Trial name
- NCT06351150
- Testing
- Angiotensin II Injection, 0.9% sodium chloride injection
- Where
- 42 sites in China
- Volunteers
- 214 people
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.